6483 Stock Overview
Original BioMedicals Co., Ltd., a biotechnology company, chemical entities to solve unmet medical needs in Taiwan.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Original BioMedicals Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$15.50 |
| 52 Week High | NT$28.00 |
| 52 Week Low | NT$14.60 |
| Beta | -0.0033 |
| 1 Month Change | -9.09% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -81.33% |
Recent News & Updates
Recent updates
Shareholder Returns
| 6483 | TW Biotechs | TW Market | |
|---|---|---|---|
| 7D | -2.2% | 2.0% | 4.0% |
| 1Y | n/a | -24.4% | 28.5% |
Return vs Industry: Insufficient data to determine how 6483 performed against the TW Biotechs industry.
Return vs Market: Insufficient data to determine how 6483 performed against the TW Market.
Price Volatility
| 6483 volatility | |
|---|---|
| 6483 Average Weekly Movement | n/a |
| Biotechs Industry Average Movement | 5.0% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in TW Market | 8.7% |
| 10% least volatile stocks in TW Market | 2.2% |
Stable Share Price: 6483 has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine 6483's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2011 | 20 | Cliff Wang | www.i-obm.com/English_Version/index.aspx |
Original BioMedicals Co., Ltd., a biotechnology company, chemical entities to solve unmet medical needs in Taiwan. It develops (A01) Radprotect, a pre-clinical product to protects against radiation exposer; (A02) CCM-Ami, which protects normal tissues from the toxic effects of chemotherapeutic agents and ionizing radiation; and ((P01)GLP-1 CCM for the treatment of type 2 diabetes. The company was founded in 2011 and is based in Taipei, Taiwan.
Original BioMedicals Co., Ltd. Fundamentals Summary
| 6483 fundamental statistics | |
|---|---|
| Market cap | NT$1.02b |
| Earnings (TTM) | -NT$59.66m |
| Revenue (TTM) | NT$43.00k |
Over9,999x
P/S Ratio-17.0x
P/E RatioIs 6483 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 6483 income statement (TTM) | |
|---|---|
| Revenue | NT$43.00k |
| Cost of Revenue | NT$8.00k |
| Gross Profit | NT$35.00k |
| Other Expenses | NT$59.70m |
| Earnings | -NT$59.66m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.91 |
| Gross Margin | 81.40% |
| Net Profit Margin | -138,746.51% |
| Debt/Equity Ratio | 0% |
How did 6483 perform over the long term?
See historical performance and comparison